Prenetics Global Limited reports developments around its consumer health sciences business, led by IM8, a premium health and longevity brand focused on daily nutrition and supplementation. Company updates commonly cover IM8 product lines such as Daily Ultimate Essentials, Daily Ultimate Longevity and The Beckham Stack, as well as brand partnerships across professional sports, preventive health testing and nutrition-access initiatives.
Recurring Prenetics news also includes financial results, earnings calls, revenue and profitability commentary, share repurchase activity, executive share purchases, balance-sheet positioning and capital allocation. Recent corporate updates reflect the company’s strategic focus on IM8 following divestitures and a shift away from digital-asset treasury expansion.
Prenetics' IM8 has launched a groundbreaking space experiment aboard the International Space Station (ISS) in collaboration with the University of Oxford, supported by Space Applications Services. The mission, launched via SpaceX CRS-31 on November 4th, aims to study accelerated aging and longevity using microgravity's unique environment.
The experiment focuses on autophagy, the cellular process of removing and recycling damaged components, using 3D organoids in a specially designed science cube. The research leverages microgravity's ability to accelerate aging processes, potentially leading to insights for improving human healthspan and astronaut health.
Coinciding with this research, IM8 officially launched its premium supplements brand on November 18th on IM8health.com, offering two products: Daily Ultimate Essentials and Daily Ultimate Longevity, now shipping to 31 countries.
Prenetics Global (NASDAQ: PRE) has announced its participation in two upcoming investor conferences in December 2024. The company will attend the iAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, where CEO Danny Yeung will present on December 10 at 10:00am ET, followed by one-on-one meetings with CFO Stephen Lo and Prenetics Americas President David Vanderveen on December 11.
Additionally, David Vanderveen will represent the company at the 13th Annual ROTH Deer Valley Event in Park City, UT from December 11-13, conducting one-on-one investor meetings throughout the conference.
Prenetics Global reported strong Q3 2024 results with revenue growing 59.4% year-over-year to $7.8 million and 30.9% sequentially. Gross profit increased 138.6% to $3.9 million, with gross margin improving to 50.8%. The company launched IM8Health.com, a premium supplements brand, shipping to 31 countries. Notable developments include Tencent's $30 million strategic investment in Insighta, validating its $200 million valuation, and the acquisition of Europa Sports Partners establishing U.S. headquarters in Charlotte. The company maintains a strong financial position with $69.1 million in cash and short-term assets, remaining debt-free, and reiterates its FY 2024 revenue target to exceed $33 million.
Prenetics (NASDAQ: PRE) and David Beckham have officially launched IM8, a health and wellness brand entering the $187 billion global consumer health market. The launch features two premium products: Daily Ultimate Essentials, an all-in-one powder with 92 nutrient-rich ingredients replacing 16 separate supplements, and Daily Ultimate Longevity, a daily capsule for cellular rejuvenation. A clinical trial showed that 93% of participants experienced increased energy levels within 30 days using Daily Ultimate Essentials. The products are available in 31 countries through IM8health.com, with subscription pricing at $79 for Essentials and $75 for Longevity. The launch follows Prenetics' acquisition of Europa, a major U.S. sports nutrition distributor.
Prenetics (NASDAQ: PRE) and David Beckham have officially launched IM8, a health and wellness brand entering the $187 billion global consumer health market. The launch introduces two premium products: Daily Ultimate Essentials, an all-in-one powder containing 92 nutrient-rich ingredients replacing 16 separate supplements, and Daily Ultimate Longevity, a daily capsule for cellular rejuvenation. Clinical trials showed significant benefits with 93% of participants experiencing increased energy levels. The products are available in 31 countries through IM8health.com, with subscription pricing at $79 for Essentials and $75 for Longevity. The launch follows Prenetics' acquisition of Europa, a major U.S. sports nutrition distributor.
Prenetics (NASDAQ: PRE) announced its participation in the upcoming Sidoti Virtual Micro Cap Conference scheduled for November 13-14, 2024. CEO Danny Yeung and CFO Stephen Lo will deliver a virtual presentation on November 13th at 8:30 a.m. ET. The presentation will be accessible through the company's investor relations website. Management will also be available for one-on-one meetings with investors on November 13th.
Prenetics Global (NASDAQ: PRE) announced a strategic US$30 million investment by Tencent in Insighta, valuing the early cancer detection company at US$200 million. This investment reduces Prenetics' stake in Insighta from 50% to 35%, while Insighta's co-founders retain their 50% shareholding. Prenetics receives US$30 million in cash from the sale of secondary shares to Tencent, boosting its pro forma cash and short-term assets to over US$90 million.
Insighta's early cancer detection platform uses proprietary FRAGMA technology, which detects DNA methylation aberrations in cell-free DNA. The company has begun clinical trials in Mainland China for liver cancer detection and plans to expand to lung cancer. With US$80 million in cash reserves, Insighta is well-funded to advance its clinical trials and commercialization efforts.
Prenetics Global (NASDAQ: PRE) has announced the acquisition of Europa Sports Partners and its subsidiary, Hubmatrix, marking a significant expansion into the $187 billion US consumer health and wellness industry. This strategic move aligns with Prenetics' recent launch of IM8, a health and wellness brand co-founded with David Beckham. Key highlights include:
1. Europa is one of the largest sports nutrition distributors in the US, with a network of 10,000+ gyms.
2. The acquisition establishes Prenetics' US headquarters in Charlotte, NC.
3. Prenetics projects $100 million+ revenue in the consumer segment for FY2025.
4. Europa distributes over 120 brands and operates three warehouses with 200,000+ sq ft of space.
5. Hubmatrix, Europa's subsidiary, provides 3PL direct-to-consumer fulfillment for health and wellness brands.
Prenetics (NASDAQ: PRE), a pioneering health sciences company, has announced a strategic partnership with international footballer and entrepreneur David Beckham. Beckham has invested in Prenetics and co-founded a new health and wellness brand, IM8, along with the company. IM8 will focus on innovative consumer health products, with further details forthcoming.
Beckham highlighted his lifelong access to top medical professionals and his excitement to work with Prenetics, a company dedicated to scientific advancements in health. Prenetics CEO Danny Yeung emphasized the transformative nature of this partnership, noting Beckham’s alignment with the company’s values of discipline, teamwork, and health.
Beckham's involvement includes collaboration with Prenetics shareholder Professor Dennis Lo, known for his pioneering work in non-invasive prenatal testing and early cancer detection. The partnership aims to drive significant contributions to the consumer health and wellness industry.
For more information, interested parties can join the waitlist at IM8health.com and follow IM8 Health on Instagram.
Prenetics Global (NASDAQ: PRE) has announced the addition of Kathryn M. Henry and David Vanderveen to its Board of Directors. This strategic move comes as Prenetics prepares to expand into the consumer health and wellness sector. CEO Danny Yeung believes that the extensive expertise of Henry and Vanderveen in consumer and health sectors will significantly enhance shareholder value. Henry brings experience from her roles at Lululemon and Gap, particularly in global information and technology operations. Vanderveen, with a robust 30-year track record in the beverage, nutrition, and technology sectors, is expected to contribute significantly to Prenetics' ambitious goals. Both directors expressed enthusiasm about their new roles and the company's potential for market disruption.